The ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillance

Por Seelige, Ruth, Washington, Allen, Bui, Jack D.
Publicado no Cytokine (2016)

Studies on the antigenicity of the NKG2D ligand H60a in tumour cells

Por Yadav, Deepak, Ngolab, Jennifer, Dang, Natalie, Bui, Jack D
Publicado em 2011

Hormesis in cancer immunology: Does the quantity of an immune reactant matter?

Por Pearce, Oliver MT, Läubli, Heinz, Bui, Jack, Varki, Ajit
Publicado em 2014

Studies of the H60a locus in C57BL/6 and 129/Sv mouse strains identify the H60a 3′UTR as a regulator of H60a expression

Por Zhang, Hui, Hardamon, Chanae, Sagoe, Bright, Ngolab, Jennifer, Bui, Jack D.
Publicado em 2010

Cutting Edge: Down-regulation of major histocompatibility complex class I-related chain A (MICA) on tumor cells by IFNγ-induced microRNA

Por Yadav, Deepak, Ngolab, Jennifer, Seung-Hwan Lim, Rod, Krishnamurthy, Siddharth, Bui, Jack D.
Publicado em 2009

Tumor-expressed IL-17D recruits NK cells to reject tumors

Por Saddawi-Konefka, Robert, O’Sullivan, Timothy, Gross, Emilie T, Washington, Allen, Bui, Jack D
Publicado no Oncoimmunology (2015)

Cancer immunoediting of the NKG2D ligand H60a

Por O’Sullivan, Timothy, Dunn, Gavin P., Lacoursiere, Daphne Y., Schreiber, Robert D., Bui, Jack D.
Publicado em 2011

uPAR Induces Expression of Transforming Growth Factor β and Interleukin-4 in Cancer Cells to Promote Tumor-Permissive Conditioning of Macrophages

Por Hu, Jingjing, Jo, Minji, Eastman, Boryana M., Gilder, Andrew S., Bui, Jack D., Gonias, Steven L.
Publicado no Am J Pathol (2014)

The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth

Por Büchau, Amanda S., Morizane, Shin, Trowbridge, Janet, Schauber, Jürgen, Kotol, Paul, Bui, Jack D., Gallo, Richard L.
Publicado em 2009

The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy

Por Peinado, Carlos, Kang, Xi, Hardamon, Chanae, Arora, Sumit, Mah, Stephen, Zhang, Hui, Ngolab, Jennifer, Bui, Jack D
Publicado em 2013

Production of unique immunotoxin cancer therapeutics in algal chloroplasts

Por Tran, Miller, Van, Christina, Barrera, Daniel J., Pettersson, Pär L., Peinado, Carlos D., Bui, Jack, Mayfield, Stephen P.
Publicado em 2013

Interleukin-17D mediates tumor rejection through recruitment of natural killer cells

Por O'Sullivan, Timothy, Saddawi-Konefka, Robert, Gross, Emilie, Tran, Miller, Mayfield, Stephen P., Ikeda, Hiroaki, Bui, Jack D.
Publicado em 2014

Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis

Por Gross, Emilie T. E., Han, Semi, Vemu, Prasantha, Peinado, Carlos D., Marsala, Martin, Ellies, Lesley G., Bui, Jack D.
Publicado no Oncoimmunology (2016)

Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

Por Shin, June Ho, Zhang, Luhua, Murillo-Sauca, Oihana, Kim, Junmo, Kohrt, Holbrook E. K., Bui, Jack D., Sunwoo, John B.
Publicado em 2013

Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies

Por Pearce, Oliver M. T., Läubli, Heinz, Verhagen, Andrea, Secrest, Patrick, Zhang, Jiquan, Varki, Nissi M., Crocker, Paul R., Bui, Jack D., Varki, Ajit
Publicado em 2014

Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology

Por Wang, Xiaoxia, Chow, Renee, Deng, Liwen, Anderson, Dan, Weidner, Noel, Godwin, Andrew K, Bewtra, Chanda, Zlotnik, Albert, Bui, Jack, Varki, Ajit, Varki, Nissi
Publicado em 2011

Morphometric analysis of immunoselection against hyperploid cancer cells

Por Bloy, Norma, Sauvat, Allan, Chaba, Kariman, Buqué, Aitziber, Humeau, Juliette, Bravo-San Pedro, José Manuel, Bui, Jack, Kepp, Oliver, Kroemer, Guido, Senovilla, Laura
Publicado no Oncotarget (2015)

Prolongation of Cardiac and Islet Allograft Survival by a Blocking Hamster Anti-Mouse CXCR3 Monoclonal Antibody

Por Uppaluri, Ravindra, Sheehan, Kathleen C.F., Wang, Liqing, Bui, Jack D., Brotman, Joshua J., Lu, Bao, Gerard, Craig, Hancock, Wayne W., Schreiber, Robert D.
Publicado em 2008

A dual function of NKG2D ligands in NK-cell activation

Por Cheney, Elizabeth E., Wise, Erica L., Bui, Jack D., Schreiber, Robert D., Carayannopoulos, Leonidas N., Spitzer, Dirk, Zafirova, Biljana, Polic, Bojan, Shaw, Andrey S., Markiewicz, Mary A.
Publicado em 2012

Drak2 is not required for tumor surveillance and suppression

Por Edwards, Benjamin A., Harris, Tarsha L., Floersh, Helen, Lukens, John R., Zaki, Md. Hasan, Vogel, Peter, Kanneganti, Thirumala-Devi, Bui, Jack D., McGargill, Maureen A.
Publicado no Int Immunol (2015)